If you are a consumer and you want to buy a blender or a new car, there are dozens of research studies available comparing cost, effectiveness, reliability, and durability.

The non-partisan consumer and government watchdog, U.S. Public Interest Research Group, threw its weight behind the recent House of Representatives health reform package today, while urging stronger action to rein in the rising cost of care for families and businesses.

More Bang for the Health Care Buck: How an Efficiency Standard for Health Insurers Can Reduce Overhead and Deliver More Patient Care, examines how much health insurers spend on health care benefits, rather than administrative overhead.

As Congress starts work on a health reform bill, a new publication from U.S. PIRG identifies a path to lower costs, not by cutting care, but by delivering better, more efficient care.

Statement of Laura Etherton, OSPIRG advocate, on passage of HB 2376 by the House Health Care Committee of the Oregon Legislature.

This afternoon, Illinois PIRG (Public Interest Research Group) was joined by State Representative Greg Harris (Chicago) and other Health and Consumer Advocacy groups to release a study that flies in the face of industry claims that increased regulation leads to higher prices for consumers.

Today, the Supreme Court stood up for patients by refusing to bow to drug company arguments that they shouldn’t be accountable for the harms their drugs may cause.

Without action from Congress, premiums for Americans with employer provided insurance will nearly double by 2016, according to a new report released today by the U.S. Public Interest Research Group.

Governor Patrick signed the Health Care Cost Control Bill that will begin to rein in aggressive and inappropriate marketing tactics by drug companies and medical device companies.

As the Legislature finalizes their work on the Health Care Cost Control Bill, MASSPIRG supports the inclusion of seven provisions in the final bill, that are especially crucial to begin to contain the cost of health care.

Statement of Laura Etherton, OSPIRG Advocate

CALPIRG Health Care Advocate Michael Russo testified today at a Department of Managed Care hearing in Irvine, calling for the enactment of new regulations to protect patients from balance billing.

MASSPIRG praised the action of the Massachusetts Senate on Thursday April 17, who adopted much needed prescription drug marketing reforms as part of the Senate President’s Health Care Cost Control Bill, S. 2650, An Act to Promote Cost Containment, Transparency and Efficiency in the Delivery of Quality Health Care.

CALPIRG released a new analysis today examining drug companies’ self-imposed limits on their marketing to doctors – efforts that include lavish wining-and-dining and thousands of dollars worth of gifts.